← FDA Drug Approvals (Drugs@FDA)

LIBRELEASE

NDA · New Drug Application · Sponsor: VALEANT PHARM INTL · Approved 1983-09-12

Drug application

FDA Application #
NDA017813
Application type
New Drug Application
Brand name
LIBRELEASE
Generic name
Chlordiazepoxide
Active ingredients
CHLORDIAZEPOXIDE
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Marketing status
Discontinued
Sponsor
VALEANT PHARM INTL
First approval
1983-09-12

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown